HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazuo Shirouzu Selected Research

antineoplaston AS 2-1

1/2014Demethylation effect of the antineoplaston AS2-1 on genes in colon cancer cells.
3/2005Effects of antineoplaston AS2-1 against post-operative lung metastasis in orthotopically implanted colon cancer in nude rat.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kazuo Shirouzu Research Topics

Disease

88Neoplasms (Cancer)
10/2015 - 01/2002
34Neoplasm Metastasis (Metastasis)
10/2015 - 01/2002
29Colorectal Neoplasms (Colorectal Cancer)
04/2016 - 01/2002
26Stomach Neoplasms (Stomach Cancer)
10/2014 - 01/2002
20Rectal Neoplasms (Rectal Cancer)
04/2017 - 01/2002
20Breast Neoplasms (Breast Cancer)
07/2015 - 12/2002
19Esophageal Neoplasms (Esophageal Cancer)
03/2012 - 01/2002
16Colonic Neoplasms (Colon Cancer)
01/2015 - 01/2003
13Carcinoma (Carcinomatosis)
08/2013 - 01/2002
10Lymphatic Metastasis
04/2014 - 05/2003
8Lung Neoplasms (Lung Cancer)
08/2012 - 05/2002
7Adenocarcinoma
04/2014 - 01/2002
7Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2014 - 01/2003
7Pancreatic Neoplasms (Pancreatic Cancer)
11/2011 - 11/2002
6Hepatocellular Carcinoma (Hepatoma)
01/2013 - 10/2004
6Carcinogenesis
06/2012 - 01/2002
5Fever (Fevers)
11/2014 - 11/2002
5Ascites
09/2010 - 10/2005
4Neutropenia
04/2016 - 04/2010
4Pathologic Constriction (Stenosis)
12/2004 - 01/2002
3Esophageal Squamous Cell Carcinoma
12/2013 - 06/2010
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2012 - 12/2005
3Fistula
10/2005 - 10/2002
3Hemorrhage
01/2004 - 01/2002
2Anorexia
04/2016 - 04/2010
2Anemia
04/2016 - 10/2005
2Necrosis
09/2012 - 10/2006
2Fibrosis (Cirrhosis)
07/2012 - 10/2005
2Liver Diseases (Liver Disease)
07/2012 - 01/2004

Drug/Important Bio-Agent (IBA)

14Fluorouracil (Carac)FDA LinkGeneric
01/2015 - 01/2002
13Proteins (Proteins, Gene)FDA Link
10/2014 - 04/2004
12Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2014 - 12/2002
9Irinotecan (Camptosar)FDA LinkGeneric
07/2015 - 07/2007
8Indicators and Reagents (Reagents)IBA
01/2017 - 01/2005
8Bevacizumab (Avastin)FDA Link
04/2016 - 01/2008
8Messenger RNA (mRNA)IBA
10/2015 - 04/2002
8Biomarkers (Surrogate Marker)IBA
09/2011 - 02/2002
7EnzymesIBA
07/2015 - 01/2004
6Trastuzumab (Herceptin)FDA Link
10/2014 - 10/2005
6CytokinesIBA
01/2014 - 10/2004
6Docetaxel (Taxotere)FDA Link
11/2013 - 11/2003
6Peptides (Polypeptides)IBA
10/2013 - 01/2002
6doxifluridineIBA
11/2007 - 10/2004
6Proliferating Cell Nuclear Antigen (PCNA)IBA
01/2006 - 07/2002
5Transcription Factors (Transcription Factor)IBA
12/2013 - 12/2007
5Cisplatin (Platino)FDA LinkGeneric
10/2013 - 01/2002
5Tumor Biomarkers (Tumor Markers)IBA
05/2012 - 11/2002
5Pharmaceutical PreparationsIBA
04/2010 - 11/2002
4Biological ProductsIBA
10/2015 - 08/2004
4GemcitabineFDA Link
07/2013 - 11/2002
4Oxygen (Dioxygen)IBA
04/2013 - 01/2004
4SiliconesIBA
01/2009 - 01/2002
4Antineoplastic Agents (Antineoplastics)IBA
03/2008 - 01/2003
4Mitogen-Activated Protein KinasesIBA
04/2006 - 12/2002
3Interleukin-6 (Interleukin 6)IBA
11/2014 - 01/2011
3InterleukinsIBA
11/2014 - 10/2006
3Paclitaxel (Taxol)FDA LinkGeneric
01/2014 - 11/2007
3Monoclonal AntibodiesIBA
11/2013 - 10/2005
3Capecitabine (Xeloda)FDA Link
04/2013 - 01/2006
3Claudin-1IBA
06/2012 - 08/2010
3Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA
06/2012 - 11/2003
3Thymidine PhosphorylaseIBA
08/2010 - 01/2006
3AntigensIBA
01/2009 - 03/2002
3Estrogen Receptor alphaIBA
03/2008 - 05/2006
3Protein Kinase CIBA
01/2008 - 02/2005
3Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2008 - 11/2003
3Transforming Growth Factor beta1 (TGF beta 1)IBA
11/2007 - 01/2003
3titanium silicide (TS-1)IBA
02/2007 - 10/2004
3Interleukin-2 (IL2)IBA
10/2006 - 12/2002
3Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
04/2006 - 11/2003
2Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2015 - 01/2011
2antineoplaston A10 (A 10)IBA
01/2015 - 08/2005
2Cetuximab (Erbitux)FDA Link
10/2014 - 05/2012
2MethylprednisoloneFDA LinkGeneric
01/2014 - 04/2002
2antineoplaston AS 2-1IBA
01/2014 - 03/2005
2Fibronectins (Fibronectin)IBA
12/2013 - 01/2011
2Epirubicin (Ellence)FDA LinkGeneric
11/2013 - 04/2005
2Cancer VaccinesIBA
10/2013 - 05/2012
2Estrogen ReceptorsIBA
11/2012 - 11/2003
2Epidermal Growth Factor (EGF)IBA
11/2012 - 03/2008
2Interleukin-8 (Interleukin 8)IBA
09/2012 - 01/2011

Therapy/Procedure

50Therapeutics
01/2017 - 01/2002
34Drug Therapy (Chemotherapy)
10/2015 - 06/2002
18Esophagectomy
03/2014 - 01/2002
16Lymph Node Excision (Lymph Node Dissection)
08/2014 - 01/2002
14Adjuvant Chemotherapy
11/2013 - 01/2002
12Gastrectomy
01/2014 - 01/2002
11Chemoradiotherapy
01/2017 - 07/2003
8Radiotherapy
07/2013 - 01/2002
7Immunotherapy
11/2007 - 03/2002
7Stents
10/2005 - 01/2002
6Proctectomy
04/2017 - 10/2006
4Laparotomy
10/2014 - 04/2002
4Aftercare (After-Treatment)
01/2014 - 01/2002
4Radiofrequency Ablation
11/2012 - 10/2004
3Hepatectomy
01/2015 - 03/2008
3Neoadjuvant Therapy
11/2013 - 09/2008
3Combined Modality Therapy
07/2013 - 01/2003
3Intra-Arterial Infusions
04/2005 - 11/2002
2Segmental Mastectomy (Lumpectomy)
11/2014 - 04/2004